National Pharmacies
The cooperative-model pharmacy where members are owners.
Independent, publicly sourced franchise intelligence for prospective buyers.
How much does a National Pharmacies franchise cost in Australia?
The total initial investment for a National Pharmacies franchise in Australia is AUD $400,000–$800,000 (estimated total entry cost including cooperative membership, fit-out, stock), based on publicly available figures.
The full report breaks down every cost category and how controllable each one is.
What are National Pharmacies's franchise fees and royalties?
National Pharmacies's published fees — royalty: 0% traditional royalty — cooperative model with profit-sharing among members; marketing levy: 0% standalone levy — marketing funded centrally through cooperative operations.
The full report maps the complete fee architecture and how each fee behaves as revenue moves.
Is a National Pharmacies franchise a good investment?
Independent analysis gives National Pharmacies a weighted risk score of 6.4 out of 10 — Elevated Risk. That is a finding, not a recommendation: suitability depends on the buyer's capital, experience, and risk tolerance.
What drives the score, and which buyer profiles the model suits, is detailed across five risk dimensions in the full report.
What do National Pharmacies franchisees regret?
A regret driver is a structural feature of a franchise system that operators most often wish they had understood before signing. These are the top 3 for National Pharmacies, by severity, from our independent analysis.
The PBS margin squeeze reality
Very HighTypically forms: Months 3–12The member-operator enters the cooperative expecting pharmacy ownership to deliver strong professional income.
The reality is that PBS dispensing margins have been progressively compressed by government policy — particularly the impact of 60-day dispensing, which halves the number of dispensing events for many chronic medications. The high-COGS environment (65–75% of revenue) leaves thin margins on the core dispensing business. The member-operator discovers that dispensing volume alone cannot sustain adequate returns and that profitability depends on front-of-shop retail, health services, and optical revenue that require different skills than clinical pharmacy.
Cooperative governance frustration
HighTypically forms: Months 6–24The entrepreneurial pharmacist joins the cooperative expecting the autonomy of business ownership.
Instead, they discover that strategic decisions are made collectively — pricing strategies, product range decisions, marketing campaigns, and capital expenditure priorities are determined by the cooperative board. The member-operator who wants to pivot quickly, introduce new services, or differentiate their store from competitors finds the cooperative governance structure slow and consensus-driven. Individual initiative is constrained by collective decision-making, and the member-operator's vote is one among many.
Capital intensity with constrained returns
HighTypically forms: Months 12–36The total entry cost of AUD $400K–$800K represents a significant capital commitment.
The member-operator who financed entry through debt discovers that pharmacy margins — particularly after PBS compression — may not generate sufficient cash flow to comfortably service debt, fund working capital, and deliver personal income that justifies the investment. The cooperative profit-sharing model distributes returns, but individual store-level profitability may not align with the member-operator's capital outlay. The regret crystallises when the member-operator calculates their return on invested capital against what the same funds could have earned in alternative investments or salaried employment.
The full report covers 2 more regret drivers, each with its formation pathway — the specific decision that locks it in — plus the complete risk architecture and 30+ due diligence questions.
Overall Risk Score
6.4
out of 10
Risk Classification
Elevated Risk
Highest Risk Area
Financial Risk
10 / 10
Report Overview
National Pharmacies is an Australian member-owned cooperative pharmacy group headquartered in Adelaide, South Australia, operating approximately 50 locations primarily across SA and Victoria. Founded in 1911, the cooperative model is fundamentally different from a traditional franchise — members buy into the cooperative rather than purchasing a franchise licence, and profits are shared among the membership base. This report provides a comprehensive, independent analysis of the National Pharmacies cooperative membership opportunity.
System Snapshot
What's in the National Pharmacies Report
Executive Intelligence Summary
National Pharmacies is one of Australia's oldest pharmacy cooperatives, founded in 1911 and operating approximately 50 pharmacies primarily across South Australia with a presence in Victoria.
Structural Economics
Observation: National Pharmacies does not charge franchise royalties or standalone marketing levies.
Cost and Fee Architecture
The cost structure of a National Pharmacies cooperative membership is characterised by the absence of traditional franchise fees, significant upfront capital requirements, and a high-COGS operating environment driven by pharmaceutical product costs and PBS pricing constraints.
Network Dynamics and Market Position
National Pharmacies has its deepest roots and strongest brand recognition in South Australia.
Operator Reality
The National Pharmacies member-operator is simultaneously a registered health professional and a retail business manager.
Profitability Structure
National Pharmacies member-operator profitability is driven by the interaction of five primary variables: (1) prescription dispensing volume, (2) front-of-shop retail revenue and margin, (3) health services income, (4) labour cost efficiency, and (5) cooperative profit distribution.
Final Intelligence Assessment
National Pharmacies is one of Australia's most enduring pharmacy operations, with a 110+ year cooperative heritage that has survived multiple transformations of the pharmacy sector.
Risk Scores Preview
High COGS environment with PBS margin compression; cooperative model distributes risk but limits individual upside
Cooperative governance limits individual autonomy; PBS policy dependency; geographic concentration in SA
Regulatory compliance burden, pharmacist staffing requirements, dual clinical-retail management
Discount pharmacy competition, online pharmacy growth, PBS reform uncertainty
Pharmacy ownership laws, cooperative governance obligations, health practitioner regulation
Not ready for the full report? Start with a Quick Check — $29 with cost data and risk traffic lights for this brand.
Get the Full Report
$197
One-time payment. Instant access. No subscription.
This report is included in the Complete Package ($1,995). Get this + 307 other reports + due diligence tools + negotiation training.
Best suited for
- Prospective franchisees evaluating National Pharmacies
- Buyers comparing multiple franchise opportunities
- Accountants or lawyers advising franchise clients
- Anyone conducting franchise due diligence
Why pay for this report?
- Saves 20+ hours of independent research
- Structured analysis you won't find in blog posts
- Risk scoring framework used by consultants
- Costs 0.01% of the franchise investment it protects
Brand reports are compiled from publicly available data and independent research. FranchiseInsights is not affiliated with any franchise brand. Information may not be current. Verify all data independently before making decisions. Produced under the FranchiseInsights Editorial Standard.